Company Overview of RiboCor, Inc.
RiboCor, Inc. develops and markets pharmaceuticals to treat prevalent chronic diseases in the United States and internationally. The company focuses in the areas of cardiovascular medicine and the treatment of fibromyalgia. It also develops products for biologic (blood banking industry) applications, such as functional enhancement of red blood cells and platelets. In addition, the company distributes Corvalen products for professional use to health care professionals, clinics, pharmacies, and their patients. RiboCor, Inc. was formerly known as Bioenergy, Inc. and changed its name to RiboCor, Inc. in April 2012. The company was founded in 1986 and is based in Minneapolis, Minnesota.
7077 Northland Circle North
Minneapolis, MN 55428
Founded in 1986
Key Executives for RiboCor, Inc.
Similar Private Companies By Industry
|Royal Health Care, Inc||United States|
|Fabre-Kramer Pharmaceuticals, Inc.||United States|
|DxCon, Inc.||United States|
|IBC Pharmaceuticals, L.L.C.||United States|
|Suncoast Clinical Research Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact RiboCor, Inc., please visit www.ribocor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.